The RSV vaccine is recommended for children aged newborn to 2 years. It helps reduce the risk of infection from Respiratory Syncytial Virus (RSV)—a leading cause of serious respiratory illnesses such as bronchiolitis and pneumonia in infants.
Vaccinating early helps build immunity before illness occurs, reducing the chances of hospitalization and severe complications during high-risk seasons.
Infants aged 0–2 years
Premature babies or children with underlying health conditions
Young children during high-risk periods, such as the rainy season or when attending daycare
Prevents severe respiratory tract infections in infants
Reduces risk of complications such as pneumonia
Lowers the chance of hospitalization
Strengthens immunity during a child’s most vulnerable stage
Recommendation
The immunization is recommended for infants under 1 year of age, especially those in high-risk groups such as premature babies or those with underlying health conditions. A consultation with a pediatrician is advised before receiving the service.
Recommendation:
For children aged 12–24 months who are at risk of RSV infection, especially those starting daycare or with school-aged siblings. Please consult a pediatrician before receiving the vaccine.
Sales period: 1 May to 31 December 2025
For more information, please contact
Department of Pediatrics and Child Development, Building 4, 2nd Floor, Tel. 02-561-1111 ext. 4201-4202
Privacy Policy | Cookie Policy
Copyright © Vibhavadi Hospital. All right reserved